NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹92 Cr | ₹72 Cr | ₹61 Cr | ₹0.34 Cr | ₹0.26 Cr |
What is the latest Contingent Liabilities ratio of NATH BIOGENES (INDIA) ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹92 Cr |
Mar2023 | ₹72 Cr |
Mar2022 | ₹61 Cr |
Mar2013 | ₹0.34 Cr |
Mar2012 | ₹0.26 Cr |
How is Contingent Liabilities of NATH BIOGENES (INDIA) Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹92 Cr | 28.60 | |
Mar2023 | ₹72 Cr | 18.58 | |
Mar2022 | ₹61 Cr | 17,668.04 | |
Mar2013 | ₹0.34 Cr | 33.73 | |
Mar2012 | ₹0.26 Cr | - |
Compare Contingent Liabilities of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹297.7 Cr | -6.3% | -13.1% | -23.7% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,995.0 Cr | -11% | -7% | 13% | Stock Analytics | |
KAVERI SEED COMPANY | ₹4,809.8 Cr | -1.8% | 3.7% | 40.3% | Stock Analytics | |
VENKYS (INDIA) | ₹2,364.2 Cr | -4.7% | -3.7% | -4.5% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,487.4 Cr | -10.6% | 1% | -38.1% | Stock Analytics | |
TIERRA AGROTECH | ₹323.6 Cr | -5% | -12.3% | -35.7% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -6.3% |
-13.1% |
-23.7% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses